Clinicopathologic conference: Bloodstream infection in an allogeneic hamatopoietic cell transplant: Thinking beyond the usual.
Fiche du document
- doi: 10.1111/tid.14273
- issn: 1398-2273
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1111/tid.14273
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/38695847
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1399-3062
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_6497609B679D1
info:eu-repo/semantics/openAccess , CC BY 4.0 , https://creativecommons.org/licenses/by/4.0/
Sujets proches
Drug therapy PharmacotherapyCiter ce document
K. Yeoh et al., « Clinicopathologic conference: Bloodstream infection in an allogeneic hamatopoietic cell transplant: Thinking beyond the usual. », Serveur académique Lausannois, ID : 10.1111/tid.14273
Métriques
Partage / Export
Résumé
This case involves a 53-year-old female with concurrent acute myeloid leukemia (AML) and multiple myeloma. She underwent cytarabine and daunorubicin (7+3) induction chemotherapy followed by cytarabine (HiDAC) consolidation, with an early AML relapse requiring azacitidine and venetoclax therapy. She achieved complete remission and incomplete count recovery. Following fludarabine, melphalan, and thymoglobulin induction chemotherapy, she underwent an allogeneic stem cell transplant with failure to engraft, requiring autologous stem cell rescue, buffy coat, and granulocyte transfusions, eventually presenting with a diffuse skin rash consistent with Steven-Johnson syndrome and toxic epidermal necrolysis, persistent neutropenic fevers and positive blood cultures.
